Nephro Care India Limited
Book Built Issue IPO · NSE
- Price band
- ₹85 - ₹90
- Lot size
- 1,600 shares
- Issue amount
- ₹41.26 cr
- Total subscription
- 770.15×
- Opens
- 28 Jun 2024
- Closes
- 2 Jul 2024
- Allotment
- 3 Jul 2024
- Listing
- 5 Jul 2024
Offer at a glance
Issue overview
- Issue size
- 45,84,000 shares
- Face value
- ₹10 Per Equity Share
- Minimum investment
- ₹1,36,000
- Fresh issue
- ₹41.26 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,44,000
- Issue type
- Book Built Issue IPO
- Shares before issue
- 1,19,02,400
- Shares after issue
- 1,64,86,400
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,600 | ₹1,44,000 |
| HNI | 2 | 3,200 | ₹2,88,000 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| — | — |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 7.43 | 1,821.48 |
| RETAIL | 13 | 8,245.6 |
Financial performance
Company financials
in ₹ Lakhs · Reported periods may include interim results.
Key performance indicators
| Metric | Dec-23 | Mar-23 | Mar-22 |
|---|---|---|---|
| EPS | 3.36 | 1.94 | -0.03 |
| ROE | 41.57 | 132.46 | -3.84 |
| ROCE | 36.56 | 71.09 | 4.13 |
| RONW | 24.42 | 79.68 | -1.98 |
| PRE IPO(PE) | 55.15 | 0 | 0 |
| POST IPO(PE) | 32.73 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Nephro Care India Limited, incorporated in 2014 and based in Kolkata, is a specialized treatment center focusing on renal insufficiency and comprehensive clinical and lifestyle solutions. Supported by expert doctors, paramedical professionals, and a skilled management team, the hospital serves approximately 900 Chronic Kidney Disease patients monthly. Operating from a 5,352 sq. ft. main clinic in Salt Lake and three satellite clinics in Salt Lake (HB 113) and Chandannagar, West Bengal, Nephro Care employs 110 staff members, including 5 permanent doctors, 10 visiting consultants, and 70 paramedical professionals. The center offers a wide range of services, including an in-house Dialysis Unit, outpatient services in nephrology, diabetology, cardiology, ophthalmology, and neurology, an NABL-accredited in-house pathology, a pharmacy, advanced diagnostics, a renal nutrition department, home care, the Mukti Lifestyle Support Program, and home dialysis services.
Strengths
- Regulatory Compliance Risks: The healthcare sector is subject to stringent regulations, and any failure to comply with applicable laws could lead to legal and financial repercussions.
- High Operational Costs: Maintaining advanced medical technology and skilled professionals requires significant investment, which could impact profitability if not managed effectively.
- Patient Dependency: The company's revenue heavily relies on patient volume, and any decline due to changing healthcare policies, competition, or patient preferences could negatively affect business performance.
Risk factors
- Location Dependency: All clinics are in Kolkata, with a major part of the company's revenue coming from the Salt Lake clinic. This makes the business sensitive to any local economic or political changes.
- Expansion Risks: The company's plan to expand into new areas like setting up a hospital could bring fresh challenges and higher risks.
- Reliance on Healthcare Professionals: The business heavily depends on its doctors and healthcare staff. Difficulty in attracting or retaining skilled professionals in the future could negatively impact its operations and growth.
Promoters
Dr. Pratim Sengupta
Registrar & documents
Lead manager
Corporate Capitalventures Private Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
Flat No-1JC-18, 5th Floor Sec-III, Salt lake Kolkata, Bidhan Nagar Sai Complex, North 24 Parganas -700098
+91 8017010197
[email protected]/Company website ↗Understanding NEPHROCARE IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.